Abstract

Summary

This review examines small molecules that can modulate the circadian clock to treat cancer and other circadian-related disorders, highlighting the growing evidence that circadian disruption is a driver of oncogenesis. While not directly focused on lighting design, the findings underscore the clinical importance of maintaining robust circadian rhythms, supporting the case for circadian-supportive lighting in healthcare environments.
Abstract

Key Findings

  • Circadian rhythm disruption is linked to increased risk of metabolic, cardiovascular, inflammatory, and cancer-related disorders.
  • Specific small molecules (clock modulators) have been identified that can target core clock components (e.g., CRY, PER, BMAL1, CLOCK) to potentially treat circadian-related diseases including cancer.
  • The review identifies several compound classes capable of lengthening or shortening circadian period, stabilizing clock proteins, or resetting phase — mechanisms relevant to chronotherapy strategies.
Categories

Categories

Sleep & Circadian Health: Reviews how circadian rhythm disruption contributes to disease, including cancer, and how small molecules can modulate clock function.
The Science of Light: Covers the molecular biology of the circadian clock, including core clock components relevant to photoentrainment and circadian regulation.
Authors

Author(s)

S Rahman, K Wittine, M Sedić, EP Markova-Car
Publication Date

Publication Year

2020
Citations

Number of Citations

13
View more publications